Infection with methicillin-resistant staphylococcus aureus after carbon dioxide resurfacing of the face: Successful treatment with minocycline, rifampin, and mupiricin ointment

Dermatologic Surgery

Volumn 24, Issue 2, 1998, Pages 279-282

  Bellman, Betty ^a,b   Brandt, Fredric S ^a   Holtmann, Marybeth ^a   Bebell, William R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ASCORBIC ACID; BETAMETHASONE; CEFADROXIL; CELLEX C; CIPROFLOXACIN; GLYCOLIC ACID; HYDROQUINONE; KETOCONAZOLE; MACROGOL; METICILLIN; MINOCYCLINE; PETROLATUM; PSEUDOMONIC ACID; RETINOIC ACID; RIFAMPICIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CARBON DIOXIDE LASER; CASE REPORT; FACE SURGERY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NOSE; ORAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

EID: 0031906686     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb04149.x     Document Type: Article

References (16)

1. Fitzpatrick RE, Goldman MP, Satur NM, Tope WD. Pulsed carbon dioxide laser resurfacing of photoaged facial skin. Arch Dermatol 1996;132:395-402.
2. Monheit GD. Facial resurfacing may trigger the herpes simplex virus. Cosmet Dermatol 1995;8:9-16.
3. 2 laser peel for improvement of acne scarring. Cosmet Dermatol 1996;9:13-5.
4. Bisaccia E, Scarborough DA. Update on rhytide removal with newer rapid-pulsed laser devices. Cosmet Dermatol 1995;8:9-12.
5. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser. Dermatol Surg 1996; 22:151-5.
6. Mulligan ME, Murray-Leisure KA, Standiford HC, et al. Methicillin Resistant Staphylococcus aureus: a consensus view of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313-28.
7. Hudson IRB. The efficacy of intranasal mupiricin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994;27:81-98.
8. Parras F, Guerrero C, Bouza E, Blazquez J et al. Comparative study of mupiricin and oral co-trimoxazole plus topical fusudic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1995;39:175-9.
9. Casewell MW, Hill RLR. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986;18(Suppl A): 1-12.
10. Forfar JO, Gould JC, Maccabe AF. Effect of hexachlorophene on incidence of staphylococcal and gram-negative infection in the newborn. Lancet 1968;11:177-9.
11. Thornsberry C. The development of antimicrobial resistance in staphylococci. J Antimicrob Chemother 1988;21(Suppl C):9-16.
12. Walsh TJ, Hansen SL, Tatem BA et al. Activity of novobiocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1985;15:435-40.
13. Slocombe B, Perry C. The antimicrobial activity of mupiricin: an update on resistance. J Hosp Infect 1991;19(Suppl B):19-25.
14. nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1992; Oct 11-14, Anaheim. Abstract no. 1688.
15. Smith GE, Kennedy CT. Staphylococcus aureus resistant to mupiricin. J Antimicrob Chemother 1988;21:141-2.
16. Segreti J, Gvazdinaskas L, Trenholme G. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis 1989;12:253-5.